Department of Pediatrics, College of Medicine, Qassim University, Qassim 51452, Saudi Arabia.
Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, LA 70118, USA; Children's Hospital of New Orleans, New Orleans, LA 70118, USA.
J Diabetes Complications. 2022 Aug;36(8):108229. doi: 10.1016/j.jdiacomp.2022.108229. Epub 2022 Jun 8.
Higher levels of HbA1c, independent of blood glucose levels, have been described in Blacks compared to Whites patients with established diabetes. The goal of this study was to determine if glucose-independent racial disparity in HbA1C is evident at diabetes onset.
We conducted a retrospective single-center chart review of 189 youth with new onset Type 1 diabetes (T1D) 60 % Whites and 40 % Blacks. HbA1c, glucose and other biochemistry measures were obtained at presentation in the Emergency Department before initiation of any therapy. HbA1c levels were adjusted for presenting glucose, self-identified race, age, gender, hematocrit, and RDW-CV.
Blacks with T1D had statistically significant higher unadjusted HbA1c (11.9 ± 1.9 vs 11.04 ± 2.0 %, p = 0.004), initial glucose (530.6 ± 230.4 vs 442 ± 211.3 mg/dL, p = 0.0075) and lower pHs (7.28 ± 0.15 vs 7.33 ± 0.12, p = 0.02) compared to white patients. Least squares means of HbA1c remained higher in Black patients even after statistical adjustment for presenting glucose, age, gender, RDW-CV, and pH. In a multiple variable model (R = 0.38, p < 0.0001) c-peptide was influenced by HCO (p = 0.0035), gender (p = 0.0092), BMI (p < 0.0001), but not race or glucose.
HbA1c at initial presentation of T1D is higher in young Black patients compared to Whites even after adjustment for glucose, age, gender, and RDW-CV. This racial disparity is consistent with other studies in individuals without diabetes and patients with long-standing diabetes under treatment.
与已确诊糖尿病的白人患者相比,黑人患者的 HbA1c 水平即使在不受血糖水平影响的情况下也更高。本研究的目的是确定在糖尿病发病时,HbA1C 是否存在与种族无关的葡萄糖差异。
我们对 189 名新诊断为 1 型糖尿病(T1D)的青少年进行了回顾性单中心病历回顾,其中 60%为白人,40%为黑人。在开始任何治疗之前,在急诊科就诊时获得 HbA1c、血糖和其他生化指标。HbA1c 水平根据就诊时的血糖、自我认定的种族、年龄、性别、红细胞压积和红细胞分布宽度-CV 进行调整。
与白人患者相比,患有 T1D 的黑人患者的未调整 HbA1c(11.9±1.9%比 11.04±2.0%,p=0.004)、初始血糖(530.6±230.4 比 442±211.3mg/dL,p=0.0075)和较低的 pH 值(7.28±0.15 比 7.33±0.12,p=0.02)均具有统计学意义。即使在对就诊时的血糖、年龄、性别、红细胞分布宽度-CV 和 pH 值进行统计调整后,黑人患者的 HbA1c 平均值仍较高。在多变量模型(R=0.38,p<0.0001)中,c-肽受 HCO3-(p=0.0035)、性别(p=0.0092)、BMI(p<0.0001)的影响,但不受种族或血糖的影响。
与白人患者相比,年轻黑人患者在 T1D 初始就诊时的 HbA1c 水平更高,即使在调整了血糖、年龄、性别和红细胞分布宽度-CV 后也是如此。这种种族差异与其他无糖尿病个体和接受长期治疗的糖尿病患者的研究一致。